Publisher's Synopsis
In the early nineteen-seventies, investment capital installed genomics and biotechnology, thus displacing prostaglandins as paradigms for medical research and treatment, along with neglect of the prostaglandin inhibiting- properties of lithium and antidepressants. This intrusion ruined any hope of clinical progress, and infl icted a deep human and economic wound on society. In the mid-seventies, Julian Lieb, M.D began to compile a list of medical disorders that respond to lithium or antidepressants, and comprise the core of this book. With the worldwide meltdown of health care, readers will find here a revolutionary approach, in which treating depression with antidepressants or lithium is often highly effective and inexpensive in preventing or treating a long list of medical disorders. It offers to free readers from the stranglehold of drug companies, medical journals, media, medical schools, government health agencies and politicians. Thus if every component of medical research, education, publishing were to collapse, many people will be able to protect themselves and their loved ones, as long as they have a humane and ethical physician to work with. With the oncoming cardiovascular, Alzheimer's, infectious disorders and cancer tsunamis, the contents of this book offer readers an opportunity to keep themselves safe. Lieb hopes that a tipping point will be reached in which governments will ensure that every citizen is offered the right to decide for themselves, whether or not to take advantage of the paradigm shift, a human right denied them for the past thirty years.
